Updated in 2021
04-30-2021 We happily announce that our US continuation patent of injectable formulation of artesunate is granted. This is the second US patent granted for this innovative formulation, which further protects our technology to fight severe malaria and reposition artesunate.
12-01-2019 We are pleased to announce that the US patent of our new injectable formulation of artesunate is officially granted. This formulation is user friendly requiring one-step to dissolve artesunate for parenteral injections, superior to Artesun which involves complicated two-step dissolution. This innovative dosage form is efficient and safer for healthcare workers in the treatment of severe malaria, and provides an ideal formulation profile to explore new indications of the drug.
Drug discovery pipeline Our mission is to create the first-in-class or best-in-class medicines to address unmet medical needs. We have developed a rich pipeline encompassing drug candidates to treat cancers, infectious diseases, skin disorders and ophthalmic diseases. We have identified six proprietary drug candidates for more than ten indications.
[About Us<] [Service] [Orders] [Catalog] [News] [Order Now] [Contact]
